SynVent is Syngene’s platform for fully integrated therapeutic discovery and development across large and small molecules.
Emerging biopharma work at the forefront of science, often venturing into disease areas where little or no real-world data exists to work with or regulatory frameworks to work within.
Our Dedicated Centers offer dedicated multi-disciplinary scientific teams, support personnel, and a tailormade ring-fenced and fire-walled infrastructure as per client specifications to support their R&D goals
Centre for Advanced Protein Studies [CAPS] is a state-of-the-art advanced national facility located in the Syngene campus, Bangalore.
Home ▸ Investors ▸ Corporate Governance ▸ Governance Reports & Policies
Syngene has engaged various vendors for delivery of goods and services. Some of such vendors qualify as micro, small and medium enterprises (“MSME”) under the Micro, Small and Medium Enterprises Development Act, 2006 (“Act”). To ensure timely payment and resolution to queries for outstanding unreconciled balances, vendors are requested to reach out to Accounts Helpdesk- Accounts.Helpdesk@Syngeneintl.com.
© 2023. Syngene International Limited